31.07.2013 • NewsDede WillamsH1 resultsLinde

Linde Confirms 2013 Forecast after Strong H1

After a strong first half, which saw operating profit rise nearly 14% to just under €2 billion and sales by 10.5% to €8.2 billion, German gases and engineering group Linde has confirmed its full-year 2013 forecast of generating earnings of "at least" €4 billion. From January to June, sales of the gases division improved by 14.5% to €7 billion and operating profit by 14.1% to €1.9 billion, said CEO Wolfgang Reitzle. In the engineering division, order intake was double the 2012 volume but revenues related to existing projects increased only 1.5% to €1.25 billion, and operating profit was flat at €148 million. 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.